Life Sciences by PointClickCare

This research emphasizes the current delta in diagnosis and treatment for asthma and COPD. Stay connected with Life Sciences by PointClickCare for the newest developments and expert content. #Healthcare #Asthma #COPD #PublicHealth #EarlyDiagnosis

When it comes to protecting residents in long-term care (LTC) facilities, the Centers for Medicare and Medicaid Services (CMS) have implemented guidelines mandating influenza vaccination before the onset of flu season. 💉🍂    Flu season typically begins in the winter months, which means that influenza vaccines become available in the fall. The CDC supports this by recommending the administration of influenza vaccines in LTC facilities by the end of October, with availability starting in September - which is only a week away! The trend in our facilities confirm this recommendation, showing a higher uptake of influenza vaccines during the fall months, tapering off as winter approaches. 🍁❄️   Given the similarities between RSV and influenza in terms of clinical characteristics (symptoms, vitals, etc.) and the anticipated time of infection, it raises the question: do GSK and Pfizer follow a similar administration timeline for their vaccines? 🤔    It is crucial to stay updated with the recommendations provided by the manufacturers and healthcare authorities. As more data becomes available, it's essential to consult trusted sources and healthcare professionals for the most accurate and up-to-date information regarding the administration of these vaccines. 💊    Remember, vaccination plays a vital role in preventing and reducing the severity of respiratory infections like RSV and influenza. By following the recommended vaccination timelines and guidelines, we can collectively work towards protecting the health and well-being of LTC residents. Let's stay informed, stay protected, and prioritize the health of our aging and vulnerable communities! 🌟💙 #VaccinationMatters #StayProtected #RSVandFluPrevention   

📢 Important RSV Treatment Update 📢    When it comes to RSV infection, it's essential to know the available management options. While there are currently no specific treatments for RSV, researchers are diligently working on developing a vaccine and antivirals to combat this respiratory virus. 🌡️💊    In the absence of targeted therapeutics, the current approach to managing RSV involves rest, staying hydrated, and using over-the-counter fever reducers and pain relievers.   According to our data, the use of bronchodilators, corticosteroids, and antipyretics has significantly increased during both 20- and 30-day RSV infections. Among these, bronchodilators demonstrated the largest observed increase, while antivirals were used the least during RSV infection. It's worth noting that previous studies have shown conflicting results regarding the long-term clinical differences between the treatment group and placebo, particularly for antivirals. 🧪🔬    Experts suggest that bronchodilators should be primarily used to alleviate bronchospasms, chronic obstructive pulmonary disease (COPD), or for individuals with a family history of asthma during RSV infections, as they can help relieve breathing restrictions. However, it's important to remember that while bronchodilators may improve breathing, they do not directly mitigate or reduce viral replication throughout the body. This is especially crucial for individuals with weaker immune systems, as inhibiting viral replication is key to managing RSV. 🌪️🩺    These findings further emphasize the urgent need for an RSV-specific treatment or preventative therapeutic. With our data sets, there is a hope for a breakthrough in RSV treatment ! 💪🙏 #RSVtreatment #StayInformed #FindACure 

This underscores the importance of comprehensive, longitudinal research to better understand and care for the aging population. Polypharmacy can lead to drug interactions, increased risk of falls, and other complications. Stay up to date on the latest news and data by following Life Sciences by PointClickCare! #Healthcare #LongitudinalData #LongTermCare #RealWorldData #PatientSafety

📢 Important RSV News: Upon reviewing our data from 2017 to 2023, the findings highlight the impact of RSV on hospitalizations within our facility resident population. 🏥    During this period, approximately 10% of the infected population in PointClickCare facilities were released to hospitals. Interestingly, this percentage aligns with similar rates observed for flu cases, which ranged from 9% to 14%. While the COVID pandemic brought about increased hospitalizations for older adults, our data suggests that those in long-term care (LTC) followed a consistent trend similar to RSV and the flu, with a 10-15% hospitalization rate year after year.     Notably, the recovery time for hospitalized residents was nearly doubled compared to the average recovery time reported in recent studies. While a full recovery from RSV is expected to take around 15 days on average, our hospitalized population experienced an average recovery time of 30 days. This emphasizes the severity and impact of RSV on individuals, particularly those who require hospital care. 🌡️⏳    These findings serve as a reminder of the need for increased awareness, prevention, and research into specific therapies for RSV. Stay informed, stay vigilant, and let's strive for a healthier future! 💪❤️ #RSVawareness #PCCcares #PreventionIsKey 

📢🦠 Did you know that RSV infections can be a prolonged burden for the aging population? According to recent studies, the average duration of RSV infections in adults is around 15 days. Comparatively, our data suggests that for the aging population, the battle with this virus can last anywhere between 19 to 28 days! That's approximately 4 to 13 days longer than the standard RSV infection in an adult. 😳😨   It's crucial to stay informed about the potential impact of RSV on aging adults, especially during the upcoming colder months when this respiratory virus tends to be more prevalent. Remember to take necessary precautions, such as practicing good hygiene and avoiding close contact with infected individuals, to reduce the risk of contracting and spreading RSV.    Stay safe and keep your loved ones protected! 🙏❤️ #RSVawareness #StayInformed #ProtectYourHealth 

Life Sciences by PointClickCare aims to change the landscape for the aging population by supporting the innovation of urgently-needed therapeutic solutions. We offer health professionals and researchers comprehensive data sets that can inform drug development, support post-market clinical studies, and drive commercialization. PointClickCare Life Sciences data offers unparalleled insights based on 6 years of patient journeys with respiratory, rheumatology, urological, and neurological conditions and indications, including, but not limited to, Alzheimer’s Disease, Parkinson’s Disease, Epilepsy, and Diabetes. Learn how de-identified health data can help you drive statistical insights: https://lnkd.in/eRuphcNT #LongTermCare #LifeSciences #biotech #pharma

Deeper Data. Better Outcomes. Our data can be a key resource to gain insights into the aging population demographic that receive care throughout various points in the health system; offering 35 or more daily observations per patient, and near real-time updates. Request your data set: https://lnkd.in/eRuphcNT #LongTermCare #LifeSciences #biotech #pharma

Why are BioPharma companies interested in the aging population and long-term care? The 65+ age demographic is set to double in size in the U.S. by 2050, which will inevitably see drastic increases in the prevalence of age-related diseases. Focusing on long-term care can significantly benefit underrepresented patients and vulnerable populations by improving access to therapies and coordinating care, leading to better outcomes. Request your data set: https://lnkd.in/eRuphcNT #LongTermCare #LifeSciences #biotech #pharma

PointClickCare Life Sciences offers deeper longitudinal data from the long-term and post-acute care (LTPAC) industry. This data is curated to help identify correlations between specific treatments and outcomes, and for gaining insights into the determinants and patterns of health-related states and events in senior care. Request your data set: https://lnkd.in/eRuphcNT #LongTermCare #LifeSciences #biotech #pharma